Estimating and disclosing the risk of developing Alzheimer’s disease: challenges, controversies and future directions

Author： Roberts J Scott   Tersegno Sarah M  

Publisher： Future Medicine

ISSN： 1479-6708

Source： Future Neurology, Vol.5, Iss.4, 2010-07, pp. : 501-517

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current approaches and future directions of gene therapy in Alzheimer's disease

By Stepanichev M.  

Neurochemical Journal, Vol. 5, Iss. 3, 2011-09 ,pp. : 159-168

MAIK Nauka/Interperiodica

Access to resources Recommend Favorite

Amyloid precursor protein and tau transgenic models of Alzheimer’s disease: insights from the past and directions for the future

By Sahara Naruhiko   Lewis Jada  

Future Neurology, Vol. 5, Iss. 3, 2010-05 ,pp. : 411-420

Future Medicine

Access to resources Recommend Favorite

Tau Therapeutics for Alzheimer’s Disease : The Promise and the Challenges

By Gold Michael  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 329-334

Humana Press, Inc

Access to resources Recommend Favorite

Suicide Risk in Alzheimer’s Disease: A Systematic Review

By  

Current Alzheimer Research, Vol. 13, Iss. 10, 2016-08 ,pp. : 1083-1099

Bentham Science Publishers

Access to resources Recommend Favorite

Apolipoprotein E4 as a target for developing new therapeutics for Alzheimer’s disease

By Refolo Lorenzo   Fillit Howard  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 151-155

Humana Press, Inc

Access to resources Recommend Favorite